Abstract
Reference genes are obligatory for accurate normalization of mRNA transcript levels across samples and experimental conditions in Real Time-polymerase chain reaction (qRT-PCR) based quantitative gene expression assays. Selection of stably expressed reference genes is therefore crucial for ensuring reproducibility of such assays. However, there is a complete dearth of data on stability of commonly used reference genes in Peripheral Blood Mononuclear Cells (PBMCs) from Type 2 diabetes mellitus (T2DM) patients. We have evaluated the gene expression stability of 4 widely used reference genes (Beta-actin, ACTB; Peptidylprolyl Isomerase B, PPIB; Tyrosine 3 Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Zeta, YWHAZ; and Glyceraldehyde-3-Phosphate Dehydrogenase, GAPDH); in PBMCs from 39 T2DM patients and 47 normoglycemic (NGT) subjects. ACTB and YWHAZ were found to be the most stable genes in PBMCs from T2DM patients and therefore, can be recommended as suitable reference genes in similar contexts. GAPDH and PPIB expressions were not stable in PBMCs from T2DM patients. On using ACTB and YWHAZ as reference genes for measuring relative expression of GAPDH and PPIB in these subjects, relative GAPDH expression was found to be significantly lower in female T2DM patients, compared to female NGT subjects [GAPDH relative normalization unit (RNU): female T2DM (n = 19), median (Q1, Q3): 9.0 (8.1, 9.9); female NGT (n = 18): median (Q1, Q3): 10.1 (9.1, 11.0); P = 0.034]. Dysregulation of GAPDH in PBMCs from female T2DM patients could be associated with sex-specific differences in pathogenesis and outcomes of T2DM.
Similar content being viewed by others
Introduction
Type 2 diabetes mellitus (T2DM) is one of the top ten causes of death worldwide1. The immune system plays a vital role in the pathogenesis of T2DM, both at a causal level and during progression of the disease2,3,4,5,6. This has implications in terms of increased risk of infections in diabetics7. Peripheral blood mononuclear cells (PBMCs) fight infection as a critical part of the immune system8 and are easily sourced and therefore, widely used representatives of the immune system from diabetics. Further, they have the potential to represent relevant features of the body's immunometabolic condition9,10. Measurement of expression of genes in PBMCs is a well-used method of deciphering the effect of drugs11,12 or of intervention regimes in randomized, controlled trials13 on the diabetic immune system. Several studies have used quantitative Real Time-polymerase chain reaction (qRT-PCR) based assays to compare transcript abundance in PBMCs of healthy vs T2DM patients14,15,16. qRT-PCR is a strong technology for detecting changes in gene expression and is regarded as the “gold standard” in the field of mRNA quantification17. However, to assure robustness and repeatability of the resultant data, this method necessitates a normalization strategy when gene expression is measured in ‘relative’ and not ‘absolute’ terms18,19. Normalization of the expression data is achieved by accounting for the variability introduced due to amount of the PCR template (complimentary DNA, cDNA, generated from mRNA transcripts, in case of gene expression assays) at the beginning of the PCR assay across the samples through use of reference or housekeeping genes as internal controls20.
A stable reference gene is expected to not show inter-subject variation or be affected by the disease condition21,22. Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH), is extensively used as a reference gene for measuring relative gene expression in PBMCs from diabetics23,24,25. Nevertheless, multiple studies have reported that hyperglycaemia can alter GAPDH expression in cultured cells and animal models26,27,28.
Meticulous selection of reference genes is of utmost importance for accurate analysis of gene expression data. Interestingly, even though PBMCs from diabetics have been extensively used for immune-associated gene expression studies, only a single study has evaluated stability of reference genes in PBMCs from type 1 diabetics exist22. There is a complete dearth of similar studies on T2DM patients. In this backdrop, the aim of this study was to evaluate stability of expression of 4 widely used reference genes: Beta-actin (ACTB), Peptidylprolyl Isomerase B (PPIB), Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Zeta (YWHAZ), and GAPDH in PBMCs from T2DM patients and healthy control subjects. The primary reason for the selection of these 4 genes in the study was that they have been widely used as reference genes in gene-expression studies on human PBMCs—GAPDH11,25, ACTB11,29, PPIB29, YWHAZ30,31. Further, the 4 genes chosen for this study have different physiological and cellular roles: cytoskeleton (ACTB)32, carbohydrate metabolism (GAPDH)33, protein folding (PPIB)34, an adapter protein in signaling pathways (YWHAZ)35. Therefore, the probability of the diabetic condition in a subset of the study subjects affecting expression of all 4 of them was likely minimal. To the best of our knowledge, this is the first study to investigate the appropriateness of these 4 potential reference genes in PBMCs, including a subgroup analysis based on sex of the subjects.
Results
Anthropometric and clinical characteristics of the study subjects
The anthropometric and clinical characteristics of the 86 study subjects are summarized in Table 1. Weight, height, BMI, waist, hip, Waist:Hip ratio, and blood pressure were similar between the NGT and T2DM groups. The T2DM group was older with a mean age of 47.6 ± 8.3 years (p ˂ 0.001). HbA1c (8.7 ± 1.7, p ˂ 0.001), fasting glucose (183.3 ± 79, p ˂ 0.001), and triglyceride (203.9 ± 99.6 mg/dL, p ˂ 0.001) levels were higher in T2DM patients.
Expression profiling of the 4 reference genes
To identify the most and the least stable reference gene in PBMCs from T2DM patients, we tested gene-expression stability of 4 potential reference genes (ACTB, YWHAZ, PPIB, and GAPDH) in PBMCs of T2DM patients (n = 39) and compared them to that of NGT subjects (n = 47). These genes were selected as they have been widely used as reference genes for gene-expression studies in PBMCs from T2DM patients14,15,16. The raw Ct values for the 4 potential reference genes for the total 86 study subjects are provided in Supplementary Table 1. The raw Ct values were not different between the NGT and T2DM groups for any of the potential reference genes evaluated (Table 2).
Expression stability analysis of the reference genes
To identify the stability of expression of the 4 potential reference genes (ACTB, PPIB, YWHAZ, and GAPDH) in PBMCs from all study samples and separately in NGT and T2DM groups, the raw Ct values were assessed using the RefFinder tool36. The raw Ct values were directly imported into the RefFinder tool, which takes into account the stability rankings generated by four algorithms: GeNORM37,38, NormFinder39, BestKeeper40, and delta Ct41 to provide a comprehensive stability ranking to the potential reference genes36,42. The stability of the 4 potential reference genes, examined using the RefFinder tool, for all samples (n = 86), NGT (n = 47), and T2DM (n = 39) groups is depicted in Fig. 1. Across all 4 algorithms used and the comprehensive ranking analysis by the RefFinder tool, ACTB and/or YWHAZ were predicted to be the most stable genes, while PPIB was consistently the least stable gene in all samples and separately in the NGT group and GAPDH was the least stable gene in the T2DM group (Fig. 1).
The comprehensive ranks of gene stability were obtained from RefFinder which assigns an appropriate weight to each gene to calculate the geometric mean from stability values obtained in the 4 algorithms as mentioned above and provides an overall final stability ranking to the genes. The most stable gene in all samples was YWHAZ while PPIB was the least stable gene (Fig. 1a). The most and least stable genes in the NGT group were YWHAZ and PPIB respectively (Fig. 1b); while in the T2DM group, the most and least stable gene were ACTB and GAPDH respectively (Fig. 1c).
In the ΔCt method, a comparison of the relative expression of pairs of genes is done for each sample, and ranks for stability are provided in accordance with the repeatability in the difference in expression across the samples41. Based on this approach, YWHAZ and PPIB were the most and least stable genes respectively in all samples and NGT group, and ACTB and GAPDH were the most and least stable genes respectively in the T2DM group (Fig. 1d, e, f).
The Bestkeeper approach determines the stability of genes based on the principle that the expression of ideal reference genes is highly correlated. The program constructs a correlative index out of it to determine the stability values (standard deviation) of the reference genes40. ACTB was predicted to be the most stable reference gene in all samples, NGT, and T2DM groups. PPIB was the least stable gene for all samples and the NGT group (Fig. 1g, h). GAPDH was the least stable gene in the T2DM group (Fig. 1i).
NormFinder is based on the consideration that any reference genes would show some extent of variation in their expression across the sample set. It predicts the stability measures based on the overall variation39. NormFinder predicted YWHAZ to be the most stable gene in the all samples and the NGT group (Fig. 1j, 1k) while ACTB was the most stable gene in the T2DM group (Fig. 1l). PPIB was the least stable gene for all samples and the NGT group (Fig. 1j, k). GAPDH was the least stable gene in the T2DM group (Fig. 1l).
The stability of reference genes in GeNorm is based on the principle that the ratio of expression between two ideal reference genes should remain the same under all experimental conditions. The algorithm measures the stability of a reference gene considering that any deviation from the expression ratio will reflect an inconsistency in the expression of either of the reference genes and any increase in this ratio indicates a corresponding decrease in gene stability. GeNorm assigns a gene stability value M to all the reference genes, which is the average pairwise variation of a gene with all other reference genes included in the study. The most stable genes are the ones with the least M values37. For all samples, NGT, and T2DM groups, the most stable genes were predicted to be ACTB/YWHAZ (Fig. 1m, n, o).
Expression stability analysis of the reference genes separately in males and females
We have additionally assessed the stability of the 4 potential reference genes separately in males (NGT: n = 29, T2DM: n = 20) and females (NGT: n = 18, T2DM: n = 19) within the NGT and T2DM groups. Within NGT males, ACTB and PPIB were consistently predicted as the most and least stable genes, respectively (Fig. 2a, c, e, g, i). For NGT females, there was no consistency in the prediction of most stable and least stable genes. However, based on comprehensive ranking by the RefFinder tool, PPIB was found to be the least stable gene in both males and females of the NGT group (Fig. 2a, b).
The four algorithms, delta Ct, BestKeeper, NormFinder, and GeNorm, as well as the RefFinder tool's comprehensive ranking, consistently predicted GAPDH to be the least stable gene in both males and females with T2DM subjects (Fig. 3). ACTB was predicted to be the most stable gene in T2DM males (Fig. 3a, c, e, g, i), while YWHAZ was predicted to be the most stable gene in T2DM females by all algorithms except Bestkeeper (Fig. 3b, d, h, j).
Relative gene expression analysis of GAPDH and PPIB
As ACTB and YWHAZ were consistently predicted to be the most stable genes and GAPDH and PPIB the least stable ones in our study samples, we next assessed relative transcript abundances of GAPDH and PPIB in our study samples using ACTB and YWHAZ as the reference genes (Fig. 4 and Supplementary Table 2). Relative expression of PPIB in NGT and T2DM groups, either overall, or separately within males and within females, was similar (Fig. 4d, f, h). Relative expression of GAPDH in NGT and T2DM groups, overall, and within males was similar (Fig. 4c, e). The relative expression of GAPDH was significantly lower in T2DM females compared to that in NGT females (P = 0.034) (Fig. 4g).
Discussion
Progression of T2DM and altered immunity go hand in hand2 with both innate3 and adaptive4 branches of the immune system implicated in causation and pathophysiology of T2DM, including at the level of developmental programming of T2DM in growth-restricted births44, leading to clinically relevant implications for increased susceptibility and worse progression of infections, including that of COVID-197. Against this backdrop, measuring gene expression changes in the PBMCs, easily sourced immune cells from human T2DM subjects, using the rapid, highly accurate and inexpensive real-time qRT-PCR technique45 forms the bedrock of advancing our understanding of the altered immune system in T2DM. However, reproducibility of qRT-PCR based relative gene expression measurements depends on choosing reference genes, whose expression remain stable across individual, tissue type, morbidity conditions and any other relevant experimental parameters10.
In the current study, we have evaluated the stability of 4 commonly used reference genes: ACTB, PPIB, YWHAZ and GAPDH in PBMCs from 86 subjects: T2DM (n = 39) and NGT (n = 47). ACTB and YWHAZ were the most stable reference genes in our study samples. As such, we recommend using ACTB and YWHAZ as reference genes when measuring relative gene expression in PBMCs in settings similar to ours.
PPIB was the least stable reference gene in PBMC samples from NGT subjects in our study. PPIB is a member of the Peptidyl-prolyl cis–trans isomerase (PPIase) family which catalyses the cis–trans isomerization of proline imidic peptide bonds and is essential for protein folding during protein synthesis in the cell46. We could not find any earlier studies evaluating the stability of PPIB expression in PBMCs from T2DM patients. Further, in contrast to our findings, Pachot et al. have recommended PPIB as a suitable reference gene for quantification of gene expression in peripheral whole blood47. However, it needs to be noted here that unlike our study, Pachot et al. had conducted measurement of PPIB by qRT-PCR in 91 whole blood samples from a combined group of inflammatory patients and healthy volunteers, without conducting further sub-group analysis on stability of expression PPIB, grouping the subjects based on either their inflammatory status or sex.
GAPDH was the least stable gene in PBMCs from T2DM patients in our study, both overall and separately in T2DM males and females. Similar to our findings, Kar et al. reported high variance in GAPDH expression in PBMCs from type 1 diabetics48. These findings are in line with prior research in animal models and cell lines on the effect of hyperglycaemia on GAPDH expression. Du et al. reported that in the aortae of wild-type mice and bovine aortic endothelial cells, hyperglycaemia-induced overproduction of superoxide decreased GAPDH activity28,49. The feed-back impact of hyperglycaemia on glucose sensitive elements in this gene might explain why GAPDH is less stable in diabetic environments28,50.
As GAPDH and PPIB were the least stable genes in our study samples, we further assessed relative expression of GAPDH and PPIB using ACTB and YWHAZ as reference genes. Unique to our study, we observed significant reduction of relative expression of GAPDH in PBMCs from T2DM females compared to that from NGT females while no difference was observed between T2DM and NGT males. Our findings are supported by those of Grindel et al. whereby they reported unacceptable high variance in PBMC GAPDH expression from 146 T2DM females in Vienna, Austria, which led to GAPDH being excluded as a reference gene in that study51. Previous studies report that sex is a critical factor in insulin action and associated metabolic pathways and therefore, in susceptibility to developing insulin resistance52. This could partially explain the higher variance in PBMC GAPDH expression that we observed in T2DM versus NGT females. Further, Bongen et al. have recently reported 144 genes as differentially expressed in PBMCs or whole blood between human males and females53. Considering such extensive differences in blood transcriptome between human males and females, in-depth prospective studies on incidence and also on progression of T2DM separately in males and females will pave the way for at least sex-specific, if not, personalized approaches in prevention and management of T2DM.
The strengths of our study include availability of detailed anthopometric, biochemical and clinical data from the subjects that formed part of this study and in-depth analysis of expression stability of genes that are routinely used as reference genes for qRT-PCR based measurements of mRNA abundance in PBMCs. Additionally, unique to this study, we observed lower relative expression of GAPDH in female T2DM PBMCs compared to those in female NGTs. This observation might have future implications in understanding sex-specific effects of T2DM on the immune system. A limitation of the current study is the number of potential reference genes that we could analyse in our study samples, due to restricted availability of samples. Few other reference genes UBE2D2, RPS18, and HPRT1, have not been included in this study as their expression had been found to be stable in human PBMCs under conditions not similar to this study. UBE2D2 and RPS18 were reported to be stable in PBMCs collected 4 weeks after influenza vaccination54. HPRT1 was found to be stably expressed in PBMCs of asthmatic patients55. It was also found to be stably expressed in PBMC cultures of pulmonary tuberculosis patients56.
To conclude, we recommend the use of YWHAZ and ACTB as reference genes in PBMC-based studies from settings similar to ours. We also report that expression of GAPDH and PPIB in PBMCs is affected by hyperglycaemia in T2DM patients making them unsuitable as references genes for measuring mRNA expression. Finally, we observed a significant reduction in relative expression of GAPDH in female T2DM patients. Lack of existing literature to understand the causes and consequences of female-specific reduction in GAPDH expression in PBMCs underlines the need for future, in-depth sex-specific mechanistic studies on T2DM in human subjects.
Methods
Study population
This is a retrospective study whereby archived PBMC samples and subject data collected as part of a larger previous study have been used. Patients and samples for this retrospective study were selected from the larger study in which normoglycemic controls (NGT) and type-2 diabetics (T2DM) had been recruited at the Molecular Physiology Lab, Division of Nutrition, St. John’s Research Institute, Bangalore. The subjects had been recruited between 2016 to 2021 from the community in and around St. John’s Research Institute, Bangalore.
The subjects for this retrospective study were selected from the larger study based on the following criteria: (1) Case group of T2DM individuals (n = 39; 20 males, 19 females (T2DM status according to the American Diabetes Association (ADA) criteria57 for T2DM: Fasting Blood Glucose > 125 mg/dL and/or HbA1c > 6.5% and/or being clinically managed for T2DM using oral hypoglycaemic agents such as metformin) and (2) Control group of NGTs (n = 47; 29 males, 18 females; availability of sufficient PBMC samples leading to appropriate quality and quantity of RNA extracted from the PBMC samples for carrying out gene expression assays.
Ethical approval
The study protocol had been approved by the Institutional Ethics Committee of St. John's Medical College and Hospital, Bangalore. The study protocol was explained in the local language of the participants and their signed, informed consent was obtained at the time of recruitment. The study protocol was carried out in accordance with relevant guidelines and regulations.
Socio-demographics, anthropometry and clinical chemistry
Detailed socio-demographic data for each subject had been collected using a structured questionnaire during subject recruitment for the previous study, from which the samples for this retrospective study were chosen. The individuals had been given the questionnaire in a language that they were most familiar with, and their responses had been recorded in English by competent personnel. Dual-energy X-ray absorptiometry (DXA; DPXMD 7254, Lunar Corporation, Madison, WI) had been used to examine anthropometric parameters for body composition. Weight and height measurements had been taken with 0.1 kg and 0.1 cm precision, respectively. During the recruitment process, each subject had a comprehensive clinical chemistry examination that included standard plasma and serum clinical chemistry assays on fasted blood samples, as described previously58.
Collection of PBMCs
During the recruitment phase for the previous study, 10 mL of blood had been collected from fasting subjects. The blood had been separated into buffy coat (containing PBMCs) and serum/plasma had been utilized for biochemical assays after it was collected. Separated buffy coats had been stored at − 80 °C. These frozen buffy coat samples have been used for the gene expression assays.
RNA extraction, quality checks and cDNA preparation
RNA was extracted from frozen buffy coats using Trizol reagent (T9424; Sigma-Aldrich, St. Louis, MO, USA), followed by phase separation using chloroform. In brief, total RNA was isolated from the aqueous phase and precipitated with an equal volume of isopropanol. The resulting RNA pellet was washed in 75% ethanol, air-dried, and solubilized in diethylpyrocarbonate treated water. The total RNA obtained was checked for its purity using the Take3 Micro-Volume Plate reader (Synergy H1 Hybrid Multi-Mode Reader, BioTek Instruments Inc, Winooski, USA). Extracted RNA samples with 260/280 and 260/230 ratios of 1.8–2.2 and ≥ 1.8, respectively, were considered for further processing59,60.
Total RNA was quantified using Ribogreen reagent (Quant-iT Ribogreen RNA Assay kit, Invitrogen, Eugene, USA) on a fluorescent microplate reader (Synergy H1 microplate reader, BioTek Instruments Inc, Winooski, USA). This was followed by DNAse treatment of the extracted RNA using DNase I kit (Sigma Aldrich, St. Louis, USA). The DNAse-treated samples were reverse transcribed to obtain cDNA using High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Luthiana) following the kit manufacturer’s instructions. The obtained cDNA was used for the estimation of transcript abundance using qRT-PCR.
qRT-PCR assays
Gene expression of ACTB, PPIB, YWHAZ and GAPDH were assessed in PBMCs from T2DM patients and NGT subjects. Primer sequences were designed for ACTB, PPIB, YWHAZ and GAPDH qRT-PCR assays (Supplementary Table 3). qRT-PCR reactions were set up in duplicates of 10 µl reactions. The PCR cycling conditions were: 95 °C for 10 min followed by 40 cycles of 95 °C for 15 s, 60 °C for 1 min. All qRT-PCR reactions were performed using SYBR Green master mix (Power SYBR Green PCR Master Mix, Thermo Fisher Scientific, USA) on a QuantStudio 6 Flex Real-Time PCR system (Thermo Fisher Scientific, USA).
Standard curves for the qRT-PCR assays were constructed using cDNA derived from the Universal Human Reference RNA (Agilent Technologies, Santa Clara, CA, USA). The PCR efficiency and correlation coefficients for linearity of the qRT-PCR assays for each housekeeping-gene ranged from 90.027–98.290% to 0.989–0.999, respectively (Supplementary Fig. S1).
Calculation of the relative expression of GAPDH and PPIB as target genes was done based on a modification of the ΔCt method. The ΔCt was calculated by subtracting the arithmetic mean of the Ct values of the stable reference genes (ACTB and YWHAZ) from the Ct value of the target gene (GAPDH/PPIB) i.e. [ΔCt = Ct(target gene)−Ct(Reference genes mean)]61. The ΔCt values were converted to relative normalization units (RNU = 15—ΔCt) according to Mukhopadhyay et al43.
Assessment of stability of reference genes
For ranking the stability of expression of ACTB, PPIB, YWHAZ and GAPDH in PBMC samples, the raw mean Ct (cycle threshold) values for the qRT-PCR assays were imported to RefFinder36, which is a web-based comprehensive tool that integrates the currently available computational programs (GeNorm, Normfinder, BestKeeper, and the comparative Delta-Ct method) to compare and rank the tested candidate reference genes. Based on the rankings from each program, RefFinder assigns an appropriate stability value to an individual gene and calculates the geometric mean of their values for the overall final ranking of the reference genes to determine its stability36.
Statistical analysis
The anthropometric and clinical baseline characteristics of the study subjects were represented as mean ± SD. Normality of distributions were examined using the Shapiro–Wilk test and Q–Q plots. Student’s t-test (for normally distributed data) or Mann Whitney U test (for non-normally distributed data) were utilized to compare the basal parameters, mean Ct values of the reference genes and relative transcript abundances of GAPDH and PPIB between the study groups. All statistical analyses were done using (Microsoft excel, 2016, Microsoft Corporation, Redmond, Washington, USA) and GraphPad Prism (Version 8, GraphPad Software, San Diego, CA, USA).
Data availability
The datasets generated and analysed during the current study that support the findings of this study are available from the corresponding author on reasonable request.
References
Wang, H. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388, 1459–1544 (2017).
Berbudi, A., Rahmadika, N., Tjahjadi, A. I. & Ruslami, R. Type 2 diabetes and its impact on the immune system. CDR 16, 442–449 (2020).
Dalmas, E. Role of innate immune cells in metabolism: from physiology to type 2 diabetes. Semin. Immunopathol. 41, 531–545 (2019).
SantaCruz-Calvo, S. et al. Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities. Nat. Rev. Endocrinol. 18, 23–42 (2022).
Kolb, H. & Mandrup-Poulsen, T. An immune origin of type 2 diabetes?. Diabetologia 48, 1038–1050 (2005).
Lontchi-Yimagou, E., Sobngwi, E., Matsha, T. E. & Kengne, A. P. Diabetes mellitus and inflammation. Curr. Diab. Rep. 13, 435–444 (2013).
Corrao, S., Pinelli, K., Vacca, M., Raspanti, M. & Argano, C. Type 2 diabetes mellitus and COVID-19: a narrative review. Front. Endocrinol. 12, 609470 (2021).
Nordström, A., Hadrévi, J., Olsson, T., Franks, P. W. & Nordström, P. Higher prevalence of type 2 diabetes in men than in women is associated with differences in visceral fat mass. J. Clin. Endocrinol. Metab. 101, 3740–3746 (2016).
Catalán, V. et al. Validation of endogenous control genes in human adipose tissue: relevance to obesity and obesity-associated Type 2 diabetes mellitus. Horm. Metab. Res. 39, 495–500 (2007).
DeFronzo, R. A. et al. Type 2 diabetes mellitus. Nat. Rev. Dis. Primers 1, 15019 (2015).
Zobel, E. H. et al. Effect of liraglutide on expression of inflammatory genes in type 2 diabetes. Sci. Rep. 11, 18522 (2021).
Ali Sangouni, A., Abdollahi, S. & Mozaffari-Khosravi, H. Effect of resveratrol supplementation on hepatic steatosis and cardiovascular indices in overweight subjects with type 2 diabetes: a double-blind, randomized controlled trial. BMC Cardiovasc. Disord. 22, 212 (2022).
Haddad Kashani, H. et al. The effects of vitamin D supplementation on signaling pathway of inflammation and oxidative stress in diabetic hemodialysis: a randomized, double-blind. Placebo-Controlled Trial. Front. Pharmacol. 9, 50 (2018).
Panagiotou, C. et al. Insufficient glucocorticoid receptor signaling and flattened salivary cortisol profile are associated with metabolic and inflammatory indices in type 2 diabetes. J. Endocrinol. Invest. 44, 37–48 (2021).
Pivovarova, O. et al. Regulation of nutrition-associated receptors in blood monocytes of normal weight and obese humans. Peptides 65, 12–19 (2015).
Gahete, M. D. et al. Changes in splicing machinery components influence, precede, and early predict the development of type 2 diabetes: from the CORDIOPREV study. EBioMedicine 37, 356–365 (2018).
VanGuilder, H. D., Vrana, K. E. & Freeman, W. M. Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques 44, 619–626 (2008).
Jacob, F. et al. Careful selection of reference genes is required for reliable performance of RT-qPCR in human normal and cancer cell lines. PLoS One 8, e59180 (2013).
De Spiegelaere, W. et al. Reference gene validation for RT-qPCR, a note on different available software packages. PLoS One 10, e0122515 (2015).
Janssens, N., Janicot, M., Perera, T. & Bakker, A. Housekeeping genes as internal standards in cancer research. Mol. Diagn. 8, 107–113 (2004).
Eisenberg, E. & Levanon, E. Y. Human housekeeping genes, revisited. Trends Genet. 29, 569–574 (2013).
Kar, P., Chawla, H., Saha, S., Tandon, N. & Goswami, R. Identification of reference housekeeping-genes for mRNA expression studies in patients with type 1 diabetes. Mol. Cell. Biochem. 417, 49–56 (2016).
Tabaei, B. S. et al. Co-Administration of vitamin E and atorvastatin improves insulin sensitivity and peroxisome proliferator-activated receptor-γ expression in type 2 diabetic patients: a randomized double-blind clinical trial. Iran. J. Med. Sci. 47, 114–122 (2022).
Wang, C. et al. T-helper 17 cell/regulatory T-cell imbalance in COPD combined with T2DM patients. COPD 16, 1425–1435 (2021).
Borzouei, S., Mohamadtaheri, M., Zamani, A. & Behzad, M. Reduced frequency and functional potency of CD49d− T regulatory cells in patients with newly diagnosed type 2 diabetes mellitus. Immunobiology 226, 152113 (2021).
Glare, E. M., Divjak, M., Bailey, M. J. & Walters, E. H. beta-Actin and GAPDH housekeeping gene expression in asthmatic airways is variable and not suitable for normalising mRNA levels. Thorax 57, 765–770 (2002).
Nasrin, N. et al. An insulin response element in the glyceraldehyde-3-phosphate dehydrogenase gene binds a nuclear protein induced by insulin in cultured cells and by nutritional manipulations in vivo. Proc. Natl. Acad. Sci. U. S. A 87, 5273–5277 (1990).
Du, X. et al. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J. Clin. Invest. 112, 1049–1057 (2003).
Saulle, I. et al. MiRNA profiling in plasma and placenta of SARS-CoV-2-infected pregnant women. Cells 10, 1788 (2021).
Alieva, AKh., Filatova, E. V., Rudenok, M. M., Slominsky, P. A. & Shadrina, M. I. Housekeeping genes for Parkinson’s disease in humans and mice. Cells 10, 2252 (2021).
Margaritis, K. et al. Micro-RNA implications in type-1 diabetes mellitus: a review of literature. IJMS 22, 12165 (2021).
Lambrechts, A., Van Troys, M. & Ampe, C. The actin cytoskeleton in normal and pathological cell motility. Int. J. Biochem. Cell Biol. 36, 1890–1909 (2004).
Schneider, M., Knuesting, J., Birkholz, O., Heinisch, J. J. & Scheibe, R. Cytosolic GAPDH as a redox-dependent regulator of energy metabolism. BMC Plant Biol. 18, 184 (2018).
Lu, H., Yang, Y., Allister, E. M., Wijesekara, N. & Wheeler, M. B. The identification of potential factors associated with the development of type 2 diabetes. Mol. Cell. Proteom. 7, 1434–1451 (2008).
Zeng, Q. Z. et al. YWHAZ Binds to TRIM21 but is not involved in TRIM21-stimulated osteosarcoma cell proliferation. Biomed. Environ. Sci. 31, 186–196 (2018).
Xie, F., Xiao, P., Chen, D., Xu, L. & Zhang, B. miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs. Plant Mol. Biol. 80, 75–84 (2012).
Vandesompele, J. et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, research00341 (2002).
Hellemans, J., Mortier, G., De Paepe, A., Speleman, F. & Vandesompele, J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 8, R19 (2007).
Andersen, C. L., Jensen, J. L. & Ørntoft, T. F. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 64, 5245–5250 (2004).
Pfaffl, M. W., Tichopad, A., Prgomet, C. & Neuvians, T. P. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: bestkeeper–excel-based tool using pair-wise correlations. Biotechnol. Lett. 26, 509–515 (2004).
Silver, N., Best, S., Jiang, J. & Thein, S. L. Selection of housekeeping genes for gene expression studies in human reticulocytes using real-time PCR. BMC Mol. Biol. 7, 33 (2006).
Kochhar, P. et al. Placental expression of RNU44, RNU48 and miR-16-5p: stability and relations with fetoplacental growth. Eur. J. Clin. Nutr. 76, 722–729 (2022).
Mukhopadhyay, A. et al. Placental expression of the insulin receptor binding protein GRB10: relation to human fetoplacental growth and fetal gender. Placenta 36, 1225–1230 (2015).
Golden, T. N. & Simmons, R. A. Immune dysfunction in developmental programming of type 2 diabetes mellitus. Nat. Rev. Endocrinol. 17, 235–245 (2021).
Abbasi, F. et al. TGF-β and IL-23 gene expression in unstimulated PBMCs of patients with diabetes. Endocrine 41, 430–434 (2012).
Takahashi, N., Hayano, T. & Suzuki, M. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 337, 473–475 (1989).
Pachot, A., Blond, J.-L., Mougin, B. & Miossec, P. Peptidylpropyl isomerase B (PPIB): a suitable reference gene for mRNA quantification in peripheral whole blood. J. Biotechnol. 114, 121–124 (2004).
Kar, P., Chawla, H., Saha, S., Tandon, N. & Goswami, R. Identification of reference housekeeping-genes for mRNA expression studies in patients with type 1 diabetes. Mol. Cell Biochem. 417, 49–56 (2016).
Du, X.-L. et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc. Natl. Acad. Sci. U.S.A. 97, 12222–12226 (2000).
Nasrin, N. et al. An insulin response element in the glyceraldehyde-3-phosphate dehydrogenase gene binds a nuclear protein induced by insulin in cultured cells and by nutritional manipulations in vivo. Proc. Natl. Acad. Sci. 87, 5273–5277 (1990).
Grindel, A. et al. Oxidative stress, DNA Damage and DNA repair in female patients with diabetes mellitus type 2. PLoS One 11, e0162082 (2016).
Mittendorfer, B. Insulin resistance: sex matters. Curr. Opin. Clin. Nutr. Metab. Care 8, 367–372 (2005).
Bongen, E. et al. Sex Differences in the blood transcriptome identify robust changes in immune cell proportions with aging and influenza infection. Cell Rep. 29, 1961–1973 (2019).
Roy, J. G., McElhaney, J. E. & Verschoor, C. P. Reliable reference genes for the quantification of mRNA in human T-cells and PBMCs stimulated with live influenza virus. BMC Immunol. 21, 4 (2020).
Dheda, K. et al. Validation of housekeeping genes for normalizing RNA expression in real-time PCR. Biotechniques 37, 118–119 (2004).
Oturai, D. B., Søndergaard, H. B., Börnsen, L., Sellebjerg, F. & Christensen, J. R. Identification of suitable reference genes for peripheral blood mononuclear cell subset studies in multiple sclerosis. Scand. J. Immunol. 83, 72–80 (2016).
American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2021. Diabetes Care 44, S15–S33 (2021).
Devi, S. et al. Acyl ethanolamides in diabetes and diabetic nephropathy: novel targets from untargeted plasma metabolomic profiles of South Asian Indian men. Sci. Rep. 9, 18117 (2019).
Dorak, M. (ed.) Real-time PCR (Taylor & Francis, 2007).
Palmirotta, R. et al. Impact of preanalytical handling and timing for peripheral blood mononuclear cells isolation and RNA studies: the experience of the interinstitutional multidisciplinary biobank (BioBIM). Int. J. Biol. Mark. 27, 90–98 (2012).
Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402–408 (2001).
Acknowledgements
The authors acknowledge financial support from DBT-RA Program in Biotechnology & Life Sciences-2019 (to AH), the Department of Biotechnology, Govt. of India (Grant Sanction order DT/PR/24342/PFN/20/1314/2017 to AM), and from the Wellcome Trust/DBT India Alliance [Fellowship awarded to AM; Grant Number IA/CPHI/19/1/504593]. Guidance provided by Prof. Anura V. Kurpad in designing of the study and setting up of screening and recruitment of human subjects is gratefully acknowledged.
Author information
Authors and Affiliations
Contributions
The authors’ individual contributions to the manuscript are as follows—A.M. and A.H.: designed the research; A.H. and B.N.: conducted subject recruitments and sample collection; A.H.: conducted the experiments; A.M. and A.H.: analysis of the data, performing statistical analyses and interpretation of the results; A.M. and A.H.: obtained funding; A.M.: had the idea for and led the writing of the manuscript and had primary responsibility for the final content of the manuscript; and all authors: critically reviewed the manuscript and read and approved the final version of the manuscript. A.M. is the guarantor of this work and is responsible for the integrity of the study design.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hazarika, A., Nongkhlaw, B. & Mukhopadhyay, A. Identification of stable reference genes in peripheral blood mononuclear cells from type 2 diabetes mellitus patients. Sci Rep 13, 486 (2023). https://doi.org/10.1038/s41598-023-27460-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-27460-3
This article is cited by
-
RefFinder: a web-based tool for comprehensively analyzing and identifying reference genes
Functional & Integrative Genomics (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.